U.S. Markets closed

Is It Time To Buy Colony Bankcorp Inc (NASDAQ:CBAN) Based Off Its PE Ratio?

Alexis Guardo

Colony Bankcorp Inc (NASDAQ:CBAN) is trading with a trailing P/E of 15.2x, which is lower than the industry average of 16.9x. Although some investors may jump to the conclusion that this is a great buying opportunity, understanding the assumptions behind the P/E ratio might change your mind. Today, I will explain what the P/E ratio is as well as what you should look out for when using it. See our latest analysis for Colony Bankcorp

Breaking down the Price-Earnings ratio

NasdaqGM:CBAN PE PEG Gauge May 28th 18

The P/E ratio is a popular ratio used in relative valuation since earnings power is a key driver of investment value. By comparing a stock’s price per share to its earnings per share, we are able to see how much investors are paying for each dollar of the company’s earnings.

P/E Calculation for CBAN

Price-Earnings Ratio = Price per share ÷ Earnings per share

CBAN Price-Earnings Ratio = $15.9 ÷ $1.045 = 15.2x

On its own, the P/E ratio doesn’t tell you much; however, it becomes extremely useful when you compare it with other similar companies. We want to compare the stock’s P/E ratio to the average of companies that have similar characteristics as CBAN, such as size and country of operation. A quick method of creating a peer group is to use companies in the same industry, which is what I will do. CBAN’s P/E of 15.2x is lower than its industry peers (16.9x), which implies that each dollar of CBAN’s earnings is being undervalued by investors. Therefore, according to this analysis, CBAN is an under-priced stock.

Assumptions to watch out for

Before you jump to the conclusion that CBAN is the perfect buying opportunity, it is important to realise that our conclusion rests on two assertions. The first is that our “similar companies” are actually similar to CBAN, or else the difference in P/E might be a result of other factors. For example, if you compared lower risk firms with CBAN, then investors would naturally value it at a lower price since it is a riskier investment. The second assumption that must hold true is that the stocks we are comparing CBAN to are fairly valued by the market. If this is violated, CBAN’s P/E may be lower than its peers as they are actually overvalued by investors.

What this means for you:

You may have already conducted fundamental analysis on the stock as a shareholder, so its current undervaluation could signal a good buying opportunity to increase your exposure to CBAN. Now that you understand the ins and outs of the PE metric, you should know to bear in mind its limitations before you make an investment decision. Remember that basing your investment decision off one metric alone is certainly not sufficient. There are many things I have not taken into account in this article and the PE ratio is very one-dimensional. If you have not done so already, I urge you to complete your research by taking a look at the following:

  1. Financial Health: Is CBAN’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
  2. Past Track Record: Has CBAN been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of CBAN’s historicals for more clarity.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.

  • 5 Painful Ways You May Have Lost Money This Year
    Business
    Investor's Business Daily

    5 Painful Ways You May Have Lost Money This Year

    Money Loser #1: Shorting Markets And Hot S&P 500 Sectors Betting against the market this year was a recipe for disaster. With the S&P 500 up so much, trying to make money on the rally's demise is a bad idea. The ProShares Short S&P 500, which rises when the S&P 500 falls, dropped nearly 22% this year.

  • Here is What Hedge Funds Think About Power Integrations Inc (POWI)
    Business
    Insider Monkey

    Here is What Hedge Funds Think About Power Integrations Inc (POWI)

    That's why we weren't surprised when hedge funds' top 20 large-cap stock picks generated a return of 37.6% in 2019 (through the end of November) and outperformed the broader market benchmark by 9.9 percentage points.This is why following the smart money sentiment is a useful tool at identifying the next stock to invest in. Is Power Integrations Inc (NASDAQ:POWI) a safe investment right now? The best stock pickers are becoming more confident.

  • Here’s the formula for paying no federal income taxes on $100,000 a year
    Business
    MarketWatch

    Here’s the formula for paying no federal income taxes on $100,000 a year

    The question of how much can we earn without paying federal income taxes is relatively easy to answer for most people. The standard deduction for a married couple is $24,400 in 2019 (if both are under 65 years old), and the top of the 0% capital-gains tax bracket is $78,750. With our daughter, we also qualify for the child tax credit ($2,000), so we could actually generate another $13,333 per year in dividends or capital gains, taxed at 15%.

  • Hedge Funds Have Never Been This Bullish On HTG Molecular Diagnostics, Inc. (HTGM)
    Business
    Insider Monkey

    Hedge Funds Have Never Been This Bullish On HTG Molecular Diagnostics, Inc. (HTGM)

    Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very smart and skilled investors. Hedge funds underperform because they are hedged.

  • Billionaire George Soros Snaps Up These 3 High-Yield Dividend Stocks
    Business
    TipRanks

    Billionaire George Soros Snaps Up These 3 High-Yield Dividend Stocks

    To watch Boyd's track record, click here) BP shares have received three recent Buy ratings, giving the stock a unanimous 'Strong Buy' from the analyst consensus. The average price target stands tall at $51.33 -- indicating a robust upside potential of 39%. See BP stock analysis on TipRanks) BP wasn't the only energy industry company that Soros was interested in.

  • Hedge Funds Have Never Been This Bullish On National Health Investors Inc (NHI)
    Business
    Insider Monkey

    Hedge Funds Have Never Been This Bullish On National Health Investors Inc (NHI)

    We aren't sure whether value stocks outperform growth, but we follow hedge fund investor letters to understand where the markets and stocks might be going. This article will lay out and discuss the hedge fund and institutional investor sentiment towards National Health Investors Inc (NYSE:NHI). National Health Investors Inc (NYSE:NHI) investors should pay attention to an increase in enthusiasm from smart money in recent months.

  • Did Hedge Funds Drop The Ball On Hecla Mining Company (HL)?
    Business
    Insider Monkey

    Did Hedge Funds Drop The Ball On Hecla Mining Company (HL)?

    One way would be to spend days of research browsing through thousands of publicly traded companies. Hedge funds and other institutional investors usually invest large amounts of capital and have to conduct due diligence while choosing their next pick. With this in mind, let's take a look at the recent hedge fund activity surrounding Hecla Mining Company (NYSE:HL).

  • Hedge Funds Are Selling AMERCO (UHAL)
    Business
    Insider Monkey

    Hedge Funds Are Selling AMERCO (UHAL)

    We analyze quarterly 13F filings of nearly 750 hedge funds and, by looking at the smart money sentiment that surrounds a stock, we can determine whether it has the potential to beat the market over the long-term. Therefore, let's take a closer look at what smart money thinks about AMERCO (NASDAQ:UHAL). AMERCO (NASDAQ:UHAL) was in 10 hedge funds' portfolios at the end of the third quarter of 2019.

  • Shares of General Electric pop after bullish UBS note
    Business
    Yahoo Finance Video

    Shares of General Electric pop after bullish UBS note

    Shares of the beleaguered, industrial conglomerate General Electric popped. This came after a UBS note on Thursday, which gave the stock a 'buy' rating. UBS also predicted a big 2020 rebound for the company.

  • Here is What Hedge Funds Think About Antares Pharma Inc (NASDAQ:ATRS)
    Business
    Insider Monkey

    Here is What Hedge Funds Think About Antares Pharma Inc (NASDAQ:ATRS)

    While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the trade war with China, many smart money investors kept their cautious approach regarding the current bull run in the third quarter and hedging or reducing many of their long positions. Some fund managers are betting on Dow hitting 40,000 to generate strong returns. In this article, we are going to take a look at the smart money sentiment surrounding Antares Pharma Inc (NASDAQ:ATRS).

  • Is Tower Semiconductor Ltd. (TSEM) A Good Stock To Buy?
    Business
    Insider Monkey

    Is Tower Semiconductor Ltd. (TSEM) A Good Stock To Buy?

    How do we determine whether Tower Semiconductor Ltd. (NASDAQ:TSEM) makes for a good investment at the moment? The number of bullish hedge fund positions moved up by 2 lately. Video: Click the image to watch our video about the top 5 most popular hedge fund stocks.

  • A Much Better Dividend Stock Than These Dividend Darlings
    Business
    Insider Monkey

    A Much Better Dividend Stock Than These Dividend Darlings

    Dividend investors usually focus on companies that have a long track record of increasing their dividends year after year. The companies with at least 25 years of consecutive dividend increases are especially favored by income oriented investors. In these situations, the losses due to share price decline might wipe out the dividend income that has been collected over the years.

  • Louisiana sues California over alligator ban
    News
    Associated Press

    Louisiana sues California over alligator ban

    Louisiana is suing the state of California over its decision to ban the import and sale of alligator products, saying the ban will hurt an important Louisiana industry and ultimately could hurt the state's wetlands. In a lawsuit filed Thursday, Louisiana said the economy surrounding alligators has played a key role in bringing back the American alligator population and is an important factor in protecting wetlands and other species besides alligators that depend on the wetlands. “California has nevertheless attempted to destroy the market for American alligator products notwithstanding the fact that no such alligators live in California," the lawsuit says.

  • The top job at NBCUniversal is opening up — who's in line?
    Business
    American City Business Journals

    The top job at NBCUniversal is opening up — who's in line?

    News broke late Thursday afternoon that Steve Burke plans to step down from the top job at NBCUniversal next year, immediately sparking speculation on who will take his place. Burke's contract as CEO of the studio and senior executive vice president at parent company Comcast Corp. is up in August 2020, but he may leave before then, according to reports. The news follows an executive shakeup at NBCUniversal in January that suggested who might take Burke's place.

  • Boris Johnson's huge victory will reshape US-UK relations and Britain's DNA
    World
    Yahoo Finance UK

    Boris Johnson's huge victory will reshape US-UK relations and Britain's DNA

    One of the first people to congratulate Boris Johnson on his party's massive victory in the UK's general election was US president Donald Trump. Further bolstering the close relationship he has developed with Johnson —so much so he even gave his private cell number to him — Trump reiterated his enthusiasm to get a trade deal done post-Brexit. While people can be forgiven that it's probably just business-as-usual between Trump and Johnson, the Tories' win means that we are about to witness a strengthening of US-UK ties, and an economic-political bromance that hasn't been seen since George W Bush and Tony Blair.

  • Hedge Funds Piling Into AudioCodes Ltd. (AUDC)
    Business
    Insider Monkey

    Hedge Funds Piling Into AudioCodes Ltd. (AUDC)

    That's why we believe it isn't a waste of time to check out hedge fund sentiment before you invest in a stock like AudioCodes Ltd. (NASDAQ:AUDC). AudioCodes Ltd. (NASDAQ:AUDC) investors should pay attention to an increase in hedge fund sentiment of late. Our calculations also showed that AUDC isn't among the 30 most popular stocks among hedge funds (click for Q3 rankings and see the video below for Q2 rankings).

  • Tips for end of year retirement planning
    Business
    Yahoo Finance Video

    Tips for end of year retirement planning

    As the year closes out, it's a good time to take stock of where your finances stand and start preparing for your financial future. Bill Smith, managing director for CBIZ MHM's National Tax Office, joined The Final Round to discuss.

  • Hedge Funds Are Betting On Aduro BioTech Inc (ADRO)
    Business
    Insider Monkey

    Hedge Funds Are Betting On Aduro BioTech Inc (ADRO)

    There were 8 hedge funds in our database with ADRO positions at the end of the previous quarter. Video: Click the image to watch our video about the top 5 most popular hedge fund stocks. In the financial world there are a large number of tools investors have at their disposal to grade stocks.

  • Bristol-Myers wins $752 million in U.S. patent case against Gilead
    Business
    Reuters

    Bristol-Myers wins $752 million in U.S. patent case against Gilead

    Bristol-Myers Squibb Co on Friday said it won a $752 million jury verdict against Gilead Sciences Inc in a U.S. patent dispute relating to technology for treating cancer. A jury in Los Angeles awarded the damages after finding that Yescarta, a treatment sold by Gilead's Kite Pharma unit, infringed on a patent exclusively licensed by Bristol-Myers' Juno Therapeutics division. The patent at issue in the lawsuit, which Juno licenses from the Memorial Sloan Kettering Cancer Center in New York, relates to CAR T-cell immunotherapy for cancer.

  • Hedge Funds Are Dumping NIO Limited (NIO)
    Business
    Insider Monkey

    Hedge Funds Are Dumping NIO Limited (NIO)

    Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that's why their assets under management continue to swell). NIO Limited (NYSE:NIO) was in 13 hedge funds' portfolios at the end of the third quarter of 2019. There were 14 hedge funds in our database with NIO holdings at the end of the previous quarter.

  • Boeing loses battle to develop long-haul plane
    Business
    American City Business Journals

    Boeing loses battle to develop long-haul plane

    The Boeing Co. has lost out to rival Airbus in the bid to develop an aircraft that Australian flagship carrier Qantas aims to introduce on ultra-long-haul flights. The plane could be used on the Chicago-to-Brisbane route that Qantas will start flying on April 15. Qantas CEO Alan Joyce said of the carrier's choice of the Airbus model aircraft: “Airbus gives us the best possible combination of commercial terms, fuel efficiency, operating cost and customer experience.” Qantas' decision to go with a version of the Airbus A350-1000 comes after Boeing (NYSE: BA) has been in the public spotlight for months as multiple agencies have investigated the development of the troubled Boeing 737 MAX.

  • Is It Worth Buying Costco Wholesale Corporation (NASDAQ:COST) For Its 0.9% Dividend Yield?
    Business
    Simply Wall St.

    Is It Worth Buying Costco Wholesale Corporation (NASDAQ:COST) For Its 0.9% Dividend Yield?

    Of the free cash flow it generated last year, Costco Wholesale paid out 31% as dividends, suggesting the dividend is affordable. It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.

  • Should You Be Concerned About Sanofi's (EPA:SAN) ROE?
    Business
    Simply Wall St.

    Should You Be Concerned About Sanofi's (EPA:SAN) ROE?

    This article is for those who would like to learn about Return On Equity (ROE). To keep the lesson grounded in practicality, we'll use ROE to better understand Sanofi (EPA:SAN). Our data shows Sanofi has a return on equity of 5.7% for the last year.

  • Simon Property Group Is Preparing Its Balance Sheet for Armageddon
    Business
    InvestorPlace

    Simon Property Group Is Preparing Its Balance Sheet for Armageddon

    Shopping centers continue to die, leaving behind vast swaths of undeveloped parking lots. While best known for owning giant malls like the 110-acre Roosevelt Field on Long Island, Simon's focus these days is on outlet malls. It competes there with Tanger Factory Outlet Centers (NYSE:SKT).

  • 10 Countries with the Highest Coffee Consumption in the World
    Business
    Insider Monkey

    10 Countries with the Highest Coffee Consumption in the World

    Coffee will never go out of fashion, as evidenced by the 10 countries with the highest coffee consumption in the world. There's a reason why one of Starbucks Corporation (NASDAQ:SBUX)'s is just a stone's throw away, McDonalds (NYSE:MCD) has opened McCafes and there are more Dunkin Donuts (NASDAQ:DNKN) than stars in the sky (unverified). Demand for coffee is huge, even though if you compare coffee consumption by country 2019 and coffee consumption by country 2018, you will notice a decline.